These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7028548

  • 1. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ, Taylor RH, Goff DV, Fielden H, Misiewicz JJ, Sarson DL, Bloom SR, Alberti KG.
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [Abstract] [Full Text] [Related]

  • 2. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J, Kemmer F, Morishima T, Berchtold P, Vranic M.
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP, Keup U, Puls W.
    Digestion; 1982 Mar; 23(4):232-8. PubMed ID: 6754513
    [Abstract] [Full Text] [Related]

  • 4. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K, Turton J.
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [Abstract] [Full Text] [Related]

  • 5. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ, Taylor RH, Nineham R, Goff DV, Bloom SR, Sarson D, Alberti KG.
    Lancet; 1979 Nov 03; 2(8149):924-7. PubMed ID: 91023
    [Abstract] [Full Text] [Related]

  • 6. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR, Ebert R, Creutzfeldt W.
    Scand J Gastroenterol; 1981 Nov 03; 16(5):629-32. PubMed ID: 7034156
    [Abstract] [Full Text] [Related]

  • 7. Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption.
    Taylor RH, Jenkins DJ, Barker HM, Fielden H, Goff DV, Misiewicz JJ, Lee DA, Allen HB, MacDonald G, Wallrabe H.
    Diabetes Care; 1982 Nov 03; 5(2):92-6. PubMed ID: 6927727
    [Abstract] [Full Text] [Related]

  • 8. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W, Fölsch UR, Elsenhans B, Ballmann M, Conlon JM.
    Scand J Gastroenterol Suppl; 1985 Nov 03; 112():45-53. PubMed ID: 3892654
    [Abstract] [Full Text] [Related]

  • 9. Effect of alpha-glucosidehydrolase inhibition and intestinal absorption of sucrose, water, and sodium in man.
    Caspary WF, Kalisch H.
    Gut; 1979 Sep 03; 20(9):750-5. PubMed ID: 387540
    [Abstract] [Full Text] [Related]

  • 10. Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man.
    Dimitriadis G, Tessari P, Go V, Gerich J.
    Metabolism; 1982 Aug 03; 31(8):841-3. PubMed ID: 7047984
    [Abstract] [Full Text] [Related]

  • 11. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
    Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G.
    Dig Dis Sci; 1992 Jul 03; 37(7):1057-64. PubMed ID: 1618053
    [Abstract] [Full Text] [Related]

  • 12. Effect of a glucosidase inhibitor on the metabolic response of diabetic rats to a high carbohydrate diet, consisting of starch and sucrose, or glucose.
    Gray RS, Olefsky JM.
    Metabolism; 1982 Jan 03; 31(1):88-92. PubMed ID: 7043164
    [Abstract] [Full Text] [Related]

  • 13. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F, Compagnucci P.
    Drug Saf; 1994 Dec 03; 11(6):432-44. PubMed ID: 7727053
    [Abstract] [Full Text] [Related]

  • 14. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
    Jenkins DJ, Taylor RH, Nineham R, Goff DV, Bloom SR, Sarson DL, Misiewicz JJ, Alberti KG.
    Am J Gastroenterol; 1988 Apr 03; 83(4):393-7. PubMed ID: 2831707
    [Abstract] [Full Text] [Related]

  • 15. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P.
    Res Exp Med (Berl); 1979 Apr 23; 175(1):81-6. PubMed ID: 375342
    [Abstract] [Full Text] [Related]

  • 16. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
    Hayakawa T, Kondo T, Okumura N, Nagai K, Shibata T, Kitagawa M.
    Am J Gastroenterol; 1989 May 23; 84(5):523-6. PubMed ID: 2655436
    [Abstract] [Full Text] [Related]

  • 17. The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice.
    Lee SM, Bustamante SA, Koldovský O.
    Metabolism; 1983 Aug 23; 32(8):793-9. PubMed ID: 6346004
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.
    Zavaroni I, Reaven GM.
    Metabolism; 1981 Apr 23; 30(4):417-20. PubMed ID: 7010078
    [Abstract] [Full Text] [Related]

  • 19. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP, Tierney AR, Kral JG, Bjorntorp P.
    Am J Clin Nutr; 1984 Aug 23; 40(2):270-6. PubMed ID: 6380264
    [Abstract] [Full Text] [Related]

  • 20. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
    Schwartzkopff W, Calder D.
    Med Welt; 1984 Feb 10; 35(6):169-74. PubMed ID: 6369065
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.